Patenting genetic materials' unresolved issues and promoting competition in biotechnology

Caufield, 1996, Patent law and human DNA: current practice Commonwealth of Australia, 1984. Patents, Innovation and Competition in Australia. Industrial Property Advisory Committee Commonwealth of Australia, 1998a. Australian patents for plants Commonwealth of Australia, 1998b. Australian Patents for: Microorganisms, cell lines, hybridomas, related biological materials and their use, genetically manipulated organisms Commonwealth of Australia, 2000a. National Biotechnology Strategy Commonwealth of Australia, 2000b. Access to Biological Resources in Commonwealth Areas. Voumard Committee Commonwealth of Australia, 2000c. Review of Intellectual Property Legislation under the Competition Principles Agreement. Intellectual Property and Competition Review Committee Commonwealth of Australia, 2001a. Government Response to the Intellectual Property and Competition Review Committee Recommendations Commonwealth of Australia, 2001b. Parliamentary Debates. House of Representatives (24 May 2001; Parliamentary Secretary to the Minister for Industry, Science and Resources) Conference of Parties to the Convention on Biological Diversity, 2001. Report of the ad hoc open-ended working group on access and benefit sharing, UNEP/CBD/COP/6/6 (including the Annex – Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of the Benefits Arising out of their Utilisation) Council for Trade-Related Aspects of Intellectual Property Rights, 2001. Submission by the African Group, Barbados, Bolivia, Brazil, Cuba, Dominican Republic, Ecuador, Honduras, India, Indonesia, Jamaica, Pakistan, Paraguay, Philippines, Peru, Sri Lanka, Thailand and Venezuela, IP/C/W/296 Dorozynski, 2001, France challenges patent for genetic screening of breast cancer, British Medical Journal, 323, 589, 10.1136/bmj.323.7313.589 Fletcher, 1990, Ethics, law and medical genetics: after the human genome is mapped, Emory Law Journal, 39, 747 Lawson, 1998, Patenting genes and gene sequences in Australia, Journal of Law and Medicine, 5, 364 Lawson, 1999, Patenting genetic diversity – old rules may be restricting the exploitation of a new technology, Journal of Law and Medicine, 6, 373 Lawson, 2000, Canada v europe union – competition and patents at the WTO, ACCC Journal, 28, 1 Lawson, 2001, Patents, substitution, imitation and competition: Amgen, TKT and the erythropoietin patents, ACCC Journal, 37, 22 Lawson, 2002, Patenting genes and gene sequences and competition: patenting at the expense of competition, Federal Law Review, 30, 97, 10.22145/flr.30.1.4 Lawson, 2002, It's patently absurd – benefit sharing genetic resources from the seas according to UNCLOS, the CBD and TRIPs, Journal of International Wildlife Law and Policy, 5, 211, 10.1080/13880290209354011 Lawson, 1998, Patent laws will undermine access provisions in the environment protection and biodiversity conservation bill 1998 (Cth), Environmental and Planning Law Journal, 15, 401 Lawson, 2000, Patenting genetic materials – failing to reflect the value of variation in DNA, RNA and amino acids, Australian Intellectual Property Journal, 11, 69 Lawson, 2001, The conflict for patented genetic materials under the convention on biological diversity and the agreement on trade related aspects of intellectual property rights, Australian Intellectual Property Journal, 12, 104 Lawson, 2002, Controlling access to genetic resources under the environment protection and biodiversity conservation act 1999 requires an assessment of the effects of the patents act 1990, Australian Intellectual Property Journal, 13, 109 McCarthy, 1985, Intellectual property and trade practices policy: coexistence or conflict? The American experience, Australian Business Law Review, 13, 198 Nicol, 2001, The Australian medical biotechnology industry and access to intellectual property: issues for patent law development, Sydney Law Review, 23, 347 Nuffield Council on Bioethics, 2002. The Ethics of Patenting DNA – A Discussion Paper. Nuffield Foundation, London Stoianoff, 1998, Access to Australia's biological resources and technology transfer, European Intellectual Property Review, 20, 298 United States Patent and Trademark Office, 2001. Utility Examination Guidelines, Federal Register 66, pp. 1092–1099 Watson, 2001, MEPs protest at patent for breast cancer gene, British Medical Journal, 323, 888, 10.1136/bmj.323.7318.888